INS and Hypoglycemia: Gla‐300 switchers had significantly lower inpatient/ED‐associated hypoglycaemia incidences than Gla‐100/IDet switchers in subgroups 1 (uncontrolled HbA1c), 2 (prandial insulin), 4 (recent hypoglycaemia), and 7 (sulphonylurea use) (Table 2).